StockData
Xencor Inc logo

Xencor Inc (XNCR) stock

XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30188% above fair value
$33.26−0.75 (-2.21%)

Close on Nov 20, 2026Market cap $2.47BP/E –Yield –

Xencor revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Xencor's revenue for the twelve months ending Jun 30, 2026 was $104.97M, down 28.6% year over year. For fiscal 2025 it was $125.58M, up 13.7% from the year before. The highest annual figure on record is $275.11M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$125.58M+13.7%
FY2024Dec 31, 2024$110.49M-36.7%
FY2023Dec 31, 2023$174.62M+6.1%
FY2022Dec 31, 2022$164.58M-40.2%
FY2021Dec 31, 2021$275.11M+124.2%
FY2020Dec 31, 2020$122.69M-21.7%
FY2019Dec 31, 2019$156.70M+285.9%
FY2018Dec 31, 2018$40.60M-12.0%
FY2017Dec 31, 2017$46.15M-57.7%
FY2016Dec 31, 2016$109.02M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$51.22M+17.5%
Q1 FY2026Mar 31, 2026$4.52M-86.2%
Q4 FY2025Dec 31, 2025$28.24M-46.5%
Q3 FY2025Sep 30, 2025$21.00M+18.0%
Q2 FY2025Jun 30, 2025$43.61M+82.4%
Q1 FY2025Mar 31, 2025$32.73M+104.6%
Q4 FY2024Dec 31, 2024$52.79M+3.6%
Q3 FY2024Sep 30, 2024$17.80M-69.9%
Q2 FY2024Jun 30, 2024$23.91M-47.5%
Q1 FY2024Mar 31, 2024$16.00M-15.6%
Q4 FY2023Dec 31, 2023$50.97M+135.8%
Q3 FY2023Sep 30, 2023$59.16M+116.7%
Q2 FY2023Jun 30, 2023$45.52M+50.9%
Q1 FY2023Mar 31, 2023$18.96M-77.8%
Q4 FY2022Dec 31, 2022$21.61M-86.0%
Q3 FY2022Sep 30, 2022$27.30M+38.7%
Q2 FY2022Jun 30, 2022$30.18M-55.3%
Q1 FY2022Mar 31, 2022$85.50M+151.7%
Q4 FY2021Dec 31, 2021$154.02M+268.0%
Q3 FY2021Sep 30, 2021$19.68M-44.3%
Q2 FY2021Jun 30, 2021$67.45M+415.3%
Q1 FY2021Mar 31, 2021$33.97M+4.9%
Q4 FY2020Dec 31, 2020$41.85M+1090.4%
Q3 FY2020Sep 30, 2020$35.37M+62.5%
Q2 FY2020Jun 30, 2020$13.09M-32.8%
Q1 FY2020Mar 31, 2020$32.39M-71.1%
Q4 FY2019Dec 31, 2019$3.52M-69.6%
Q3 FY2019Sep 30, 2019$21.76M-25.1%
Q2 FY2019Jun 30, 2019$19.49M-35.4%
Q1 FY2019Mar 31, 2019$111.94M–
Q4 FY2018Dec 31, 2018$11.56M-7.5%
Q3 FY2018Sep 30, 2018$29.04M+729.7%
Q4 FY2017Dec 31, 2017$30.15M–
Q3 FY2017Sep 30, 2017$0–
Q2 FY2017Jun 30, 2017$12.50M–
Q1 FY2017Mar 31, 2017$3.50M–

More Xencor figures

See a number that looks wrong?